Afya (NASDAQ:AFYA) VP Lelio De Souza Junior Sells 41,541 Shares of Stock

Afya Limited (NASDAQ:AFYAGet Free Report) VP Lelio De Souza Junior sold 41,541 shares of the business’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $15.00, for a total value of $623,115.00. Following the completion of the transaction, the vice president directly owned 36,204 shares in the company, valued at approximately $543,060. This represents a 53.43% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Lelio De Souza Junior also recently made the following trade(s):

  • On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total value of $236,533.87.
  • On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total value of $399,957.35.

Afya Stock Performance

Afya stock opened at $14.84 on Wednesday. The stock has a 50-day simple moving average of $14.31 and a 200 day simple moving average of $14.53. The stock has a market capitalization of $1.39 billion, a price-to-earnings ratio of 9.70, a P/E/G ratio of 1.53 and a beta of 0.34. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya Limited has a 12-month low of $13.00 and a 12-month high of $18.16.

Hedge Funds Weigh In On Afya

Several large investors have recently bought and sold shares of AFYA. XTX Topco Ltd bought a new position in Afya in the fourth quarter valued at approximately $215,000. Mangrove Partners IM LLC bought a new stake in shares of Afya during the 4th quarter valued at $197,000. State Street Corp lifted its stake in shares of Afya by 25.8% in the 4th quarter. State Street Corp now owns 126,914 shares of the company’s stock valued at $1,955,000 after purchasing an additional 26,005 shares during the period. Campbell & CO Investment Adviser LLC lifted its stake in shares of Afya by 45.3% in the 4th quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company’s stock valued at $612,000 after purchasing an additional 12,365 shares during the period. Finally, Banco BTG Pactual S.A. bought a new position in shares of Afya in the 4th quarter worth $462,000. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on AFYA shares. Zacks Research lowered shares of Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Monday, April 20th. Finally, JPMorgan Chase & Co. lowered their target price on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, Afya currently has an average rating of “Hold” and an average price target of $17.10.

View Our Latest Report on AFYA

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

See Also

Insider Buying and Selling by Quarter for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.